Abstract

Cerebrovascular diseases and diabetes mellitus are among the leading medical and social problems. The main factor causing the development of polyneuropathy, angiopathy and brain damage in patients with diabetes mellitus is chronic hyperglycemia. Diabetic polyneuropathy is recognized as the most frequent specific complication of diabetes mellitus. Its diagnosis in the presence of sensory, motor, cognitive and speech disorders in patients with cerebrovascular pathology can be difficult. Modern strategies for the treatment of diabetic polyneuropathy involve the prescription of antioxidant drugs, primarily alpha-lipoic acid. The article discusses the possibilities and prospects for the use of alpha-lipoic acid in diabetic polyneuropathy and cerebrovascular diseases.